Related Experiment Videos
Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases
Insights
Juvenile dermatomyositis prognosis is linked to initial steroid response and pharyngeal involvement. Early steroid effectiveness and less severe throat issues predict a good outcome for children with this autoimmune disease.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Dermatology
Background:
- Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children.
- Understanding prognostic factors in JDM is crucial for effective management.
- Pharyngeal involvement can be a serious complication in JDM.
Purpose of the Study:
- To identify predictors of prognosis in juvenile dermatomyositis.
- To compare characteristics of patients with good versus poor outcomes.
- To analyze the impact of pharyngeal involvement on JDM mortality.
Main Methods:
- Retrospective multicenter study.
- Inclusion of 70 patients diagnosed with juvenile dermatomyositis.
- Analysis of clinical data, treatment response, and patient outcomes over at least two years of follow-up.
Main Results:
- A good prognosis subgroup showed significantly better initial response to steroids (P < 0.001).
- Less frequent pharyngeal involvement was observed in the good prognosis group.
- Patients who died had more severe pharyngeal involvement compared to survivors (P < 0.05).
Conclusions:
- Initial steroid responsiveness is a key indicator of favorable prognosis in JDM.
- Pharyngeal involvement severity is associated with JDM outcomes, including mortality.
- Early and effective treatment may improve long-term prognosis for children with JDM.
Abstract:
A retrospective multicenter study was conducted with 70 patients with juvenile dermatopolymyositis. Among survivors with sufficient follow-up (at least two years), a good prognosis subgroup was characterized by significantly better (P less than 0.001) initial response to steroids and less frequent pharyngeal involvement when compared to other patients in a poor prognosis subgroup with significant sequelae or still active disease. Patients who died had more severe pharyngeal involvement than those who survived (P less than 0.05).